• Annals of surgery · Jan 2021

    Randomized Controlled Trial Multicenter Study Comparative Study

    Synthetic Versus Biological Mesh in Laparoscopic and Open Ventral Hernia Repair (LAPSIS): Results of a Multinational, Randomized, Controlled, and Double-blind Trial.

    • Marc Miserez, Rolf Lefering, Federico Famiglietti, Tim Mathes, Dörthe Seidel, Stefan Sauerland, Dragan Korolija, Markus Heiss, Gyorgy Weber, Ferdinando Agresta, Willem-Hans Steup, Maciej Śmietański, Rui Ribeiro, Diego Cuccurullo, Fausto Catena, Claudia Rudroff, Georg Rosanelli, Fabian Schön, Bart Smet, Frank Wenger, Stefano Saad, Lars Naver, and Edmund Neugebauer.
    • Department of Abdominal Surgery, University Hospital Gasthuisberg, KU Leuven, Leuven, Belgium.
    • Ann. Surg. 2021 Jan 1; 273 (1): 57-65.

    ObjectiveThe aim of this study was to investigate the approach (open or laparoscopic) and mesh type (synthetic or biological) in ventral hernias in a clean setting.Summary of Background Data: The level of evidence on the optimal surgical approach and type of mesh in ventral hernia repair is still low.MethodsPatients with a ventral abdominal hernia (diameter 4-10 cm) were included in this double-blind randomized controlled trial across 17 hospitals in 10 European countries. According to a 2 × 2-factorial design, patients were allocated to 4 arms (open retromuscular or laparoscopic intraperitoneal, with synthetic or Surgisis Gold biological mesh). Patients and outcome assessors were blinded to mesh type used. Major postoperative complication rate (hernia recurrence, mesh infection, or reoperation) within 3 years after surgery, was the primary endpoint in the intention-to-treat population.ResultsBetween September 1st, 2005, and August 7th, 2009, 253 patients were randomized and 13 excluded. Six of 61 patients (9.8%) in the open synthetic mesh arm, 15 of 66 patients (22.7%) in the open biological mesh arm, 7 of 64 patients (10.9%) in the laparoscopic synthetic mesh arm and 17 of 62 patients (27.4%) in the laparoscopic biological mesh arm had a major complication. The use of biological mesh resulted in significantly more complications (P = 0.013), also after adjusting for hernia type, body mass index, and study site. The trial was prematurely stopped due to an unacceptable high recurrence rate in the biological mesh arms.ConclusionsThe use of Surgisis Gold biological mesh is not recommended for noncomplex ventral hernia repair.Trial RegistrationThis trial was registered at controlled-trials.com (ISRCTN34532248).Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…